Evidence map›Paper›PMID 38030969›Full record

ArticleInternational journal of emergency medicine2023

Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries.

Odd Martin Vallersnes, Alison M Dines, David M Wood, Fridtjof Heyerdahl, Knut Erik Hovda, Christopher Yates, Isabelle Giraudon, Blazena Caganova, Alessandro Ceschi, Miguel Galicia and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal of emergency medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 8 countries.

Odd Martin VallersnesDepartment of General Practice, University of Oslo, PB 1130, Blindern, Oslo, 0318, Norway. o.m.vallersnes@medisin.uio.no.
Alison M DinesClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
David M WoodClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
Fridtjof HeyerdahlPrehospital Division, Oslo University Hospital, Oslo, Norway.
Knut Erik HovdaInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Christopher YatesEmergency Department and Clinical Toxicology Unit, Hospital Universitari Son Espases, Palma, Spain.
Isabelle GiraudonEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
Blazena CaganovaNational Toxicological Information Centre, University Hospital, Bratislava, Slovakia.
Alessandro CeschiDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Miguel GaliciaEmergency Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Evangelia LiakoniClinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Matthias E LiechtiClinical Pharmacology and Toxicology, University Hospital and University of Basel, Basel, Switzerland.
Òscar MiróEmergency Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Roberta NosedaDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Per Sverre PersettDepartment of Acute Medicine, Oslo University Hospital, Oslo, Norway.
Kristiina PõldEmergeny Medicine Department, North-Estonia Medical Centre, Tallinn, Estonia.
Yasmin SchmidClinical Pharmacology and Toxicology, University Hospital and University of Basel, Basel, Switzerland.
Irene ScholzClinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Federico VigoritaSan Gerardo Hospital [U.O.S. Pronto Soccorso], ASST, Monza, Italy.
Paul I DarganClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
University of Oslo · NOEnte Ospedaliero Cantonale · CHGuy's and St Thomas' NHS Foundation Trust · GBAzienda Ospedaliera San Gerardo · ITComenius University Bratislava · SKEuropean Monitoring Centre for Drugs and Drug Addiction · PTHospital Clínic de Barcelona · ESHospital Universitario Son Espases · ESKings Health Partners · GBNorth Estonia Medical Centre · EEOslo University Hospital · NOUniversitat de Barcelona · ESUniversity Hospital of Basel · CHUniversity Hospital of Bern · CHUniversity of Basel · CHUniversity of Bern · CH

Funding

DPIP/ISEC Programme of the European Union JUST/2012/DPIP/AG/3591
6 · The paper itself

Abstract

backgroundSelf-discharge is a risk factor for readmission and excess mortality. We assess the rate of self-discharge from the emergency department (ED) among presentations for acute recreational drug toxicity and identify factors associated with self-discharge.

methodsFrom the Euro-DEN Plus database of presentations to the ED with acute recreational drug toxicity, we extracted data from 11 centres in seven European countries from 2014 to 2017. Self-discharge was defined as taking one's own discharge or escaping from the ED before being medically cleared. We used multiple logistic regression analyses to look for factors associated with self-discharge.

resultsAmong 15,135 included presentations, 1807 (11.9%) self-discharged. Self-discharge rates varied from 1.7 to 17.1% between centres. Synthetic cannabinoids were associated with self-discharge, adjusted odds ratio 1.44 (95% confidence interval 1.10-1.89), as were heroin, 1.44 (1.26-1.64), agitation, 1.27 (1.10-1.46), and naloxone treatment, 1.27 (1.07-1.51), while sedation protected from self-discharge, 0.38 (0.30-0.48).

conclusionOne in eight presentations self-discharged. There was a large variation in self-discharge rates across the participating centres, possibly partly reflecting different discharge procedures and practices. Measures to improve the management of agitation and cautious administration of naloxone to avoid opioid withdrawal symptoms may be approaches worth exploring to reduce self-discharge.

Indexed as

Discharge against medical adviceIntoxicationLeaving against medical adviceLeaving without being seenOpioidsPoisoningRecreational drug toxicitySelf-dischargeSubstances of abuseSubstance use

Identifiers

PMID38030969
PMCPMC10685690
OpenAlexW4389142737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.